» Articles » PMID: 25465621

MiR-543 and MiR-590-3p Regulate Human Mesenchymal Stem Cell Aging Via Direct Targeting of AIMP3/p18

Overview
Journal Age (Dordr)
Publisher Springer
Specialty Geriatrics
Date 2014 Dec 4
PMID 25465621
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Previously, AIMP3 (aminoacyl-tRNAsynthetase-interacting multifunctional protein-3) was shown to be involved in the macromolecular tRNA synthetase complex or to act as a tumor suppressor. In this study, we report a novel role of AIMP3/p18 in the cellular aging of human mesenchymal stem cells (hMSCs). We found that AIMP3/p18 expression significantly increased in senescent hMSCs and in aged mouse bone marrow-derived MSCs (mBM-MSCs). AIMP3/p18 overexpression is sufficient to induce the cellular senescence phenotypes with compromised clonogenicity and adipogenic differentiation potential. To identify the upstream regulators of AIMP3/p18 during senescence, we screened for potential epigenetic regulators and for miRNAs. We found that the levels of miR-543 and miR-590-3p significantly decreased under senescence-inducing conditions, whereas the AIMP3/p18 protein levels increased. We demonstrate for the first time that miR-543 and miR-590-3p are able to decrease AIMP3/p18 expression levels through direct binding to the AIMP/p18 transcripts, which further compromised the induction of the senescence phenotype. Taken together, our data demonstrate that AIMP3/p18 regulates cellular aging in hMSCs possibly through miR-543 and miR-590-3p.

Citing Articles

High-Intensity Interval Training Mitigates Sarcopenia and Suppresses the Myoblast Senescence Regulator EEF1E1.

Dun Y, Zhang W, Du Y, Xie K, Liu Y, Li C J Cachexia Sarcopenia Muscle. 2024; 15(6):2574-2585.

PMID: 39276001 PMC: 11634493. DOI: 10.1002/jcsm.13600.


Genetic and Epigenetic Interactions Involved in Senescence of Stem Cells.

Iordache F, Petcu A, Alexandru D Int J Mol Sci. 2024; 25(17).

PMID: 39273655 PMC: 11396476. DOI: 10.3390/ijms25179708.


miR-873-5p Suppression Reinvigorates Aging Mesenchymal Stem Cells and Improves Cardiac Repair after Myocardial Infarction.

Zhu W, Du W, Duan R, Liu Y, Zong B, Jin X ACS Pharmacol Transl Sci. 2024; 7(3):743-756.

PMID: 38481697 PMC: 10928897. DOI: 10.1021/acsptsci.3c00293.


Consequences of Aging on Bone.

Zhang L, Guan Q, Wang Z, Feng J, Zou J, Gao B Aging Dis. 2023; 15(6):2417-2452.

PMID: 38029404 PMC: 11567267. DOI: 10.14336/AD.2023.1115.


Alkylating anticancer agents and their relations to microRNAs.

Biersack B Cancer Drug Resist. 2022; 2(1):1-17.

PMID: 35582140 PMC: 9019174. DOI: 10.20517/cdr.2019.09.


References
1.
Chang B, Broude E, Dokmanovic M, Zhu H, Ruth A, Xuan Y . A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 1999; 59(15):3761-7. View

2.
Bringold F, Serrano M . Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol. 2000; 35(3):317-29. DOI: 10.1016/s0531-5565(00)00083-8. View

3.
Smith J, Daniel R . Stem cells and aging: a chicken-or-the-egg issue?. Aging Dis. 2012; 3(3):260-8. PMC: 3375082. View

4.
Oh Y, Kim D, Kim G, Choi E, Kennedy B, Suh Y . Downregulation of lamin A by tumor suppressor AIMP3/p18 leads to a progeroid phenotype in mice. Aging Cell. 2010; 9(5):810-22. DOI: 10.1111/j.1474-9726.2010.00614.x. View

5.
Fehrer C, Lepperdinger G . Mesenchymal stem cell aging. Exp Gerontol. 2005; 40(12):926-30. DOI: 10.1016/j.exger.2005.07.006. View